三棵樹(603737.SH):實控人洪傑持股升至67.01%
格隆匯 10 月 19日丨三棵樹(603737.SH)公佈,此次非公開發行的新增股份已於2020年10月16日在中國證券登記結算有限責任公司上海分公司辦理完畢股份登記手續,洪傑通過非公開發行方式增持公司股份818.8331萬股,佔發行前公司總股本的3.14%。洪傑為公司控股股東及實際控制人,此次權益變動完成後洪傑直接及間接持有公司股份180,194,470股,佔發行後公司總股本的67.01%。
此次權益變動後,信息披露義務人洪傑持有公司股份比例將從65.97%增加至67.01%,權益變動比例超過1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.